GOLD in practice: chronic obstructive pulmonary disease treatment and management in the primary care setting

BP Yawn, ML Mintz, DE Doherty - International journal of chronic …, 2021 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and
mortality. Early detection and appropriate treatment and management of COPD can lower …

Sing Your Lungs Out—a community singing group for chronic obstructive pulmonary disease: a 1-year pilot study

A McNaughton, M Weatherall, M Williams… - BMJ open, 2017 - bmjopen.bmj.com
Objective Singing group participation may benefit patients with chronic obstructive
pulmonary disease (COPD). Previous studies are limited by small numbers of participants …

DT-0111: a novel drug-candidate for the treatment of COPD and chronic cough

A Pelleg, F Xu, J Zhuang, B Undem… - … in respiratory disease, 2019 - journals.sagepub.com
Background: Extracellular adenosine 5′-triphosphate (ATP) plays important mechanistic
roles in pulmonary disorders in general and chronic obstructive pulmonary disease (COPD) …

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

JA Wedzicha, N Zhong, M Ichinose… - … journal of chronic …, 2017 - Taylor & Francis
Background The FLAME study demonstrated that indacaterol/glycopyrronium (IND/GLY), the
fixed-dose combination of a long-acting β2-agonist (LABA, IND) and a long-acting …

Insights into glucocorticoid responses derived from omics studies

M Kan, BE Himes - Pharmacology & therapeutics, 2021 - Elsevier
Glucocorticoid drugs are commonly used in the treatment of several conditions, including
autoimmune diseases, asthma and cancer. Despite their widespread use and knowledge of …

Inhaled corticosteroid use and the incidence of lung cancer in COPD

S Suissa, S Dell'Aniello, AV Gonzalez… - European Respiratory …, 2020 - Eur Respiratory Soc
Background Inhaled corticosteroids (ICS) are suggested for potential chemoprevention of
lung cancer. Several observational studies in patients with chronic obstructive pulmonary …

SUL-151 decreases airway neutrophilia as a prophylactic and therapeutic treatment in mice after cigarette smoke exposure

L Wang, CE Pelgrim, DH Swart, G Krenning… - International journal of …, 2021 - mdpi.com
Chronic obstructive pulmonary disease (COPD) caused by cigarette smoke (CS) is featured
by oxidative stress and chronic inflammation. Due to the poor efficacy of standard …

Microencapsulation of fluticasone propionate and salmeterol xinafoate in modified chitosan microparticles for release optimization

NM Ainali, E Xanthopoulou, G Michailidou… - Molecules, 2020 - mdpi.com
Chitosan (CS) is a natural polysaccharide, widely studied in the past due to its unique
properties such as biocompatibility, biodegradability and non-toxicity. Chemical modification …

A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease

A D'Urzo, JF Donohue, P Kardos… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Inhaled corticosteroids (ICS)(in fixed combinations with long-acting β2-agonists
[LABAs]) are frequently prescribed for patients with chronic obstructive pulmonary disease …

Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery

P Sharma, DS Dhanjal, C Chopra… - Chemico-Biological …, 2022 - Elsevier
Abstract Asthma, COPD, COVID-19, EGPA, Lung cancer, and Pneumonia are major chronic
respiratory diseases (or CRDs) affecting millions worldwide and account for substantial …